Predicting factors for progression of the myopia in the MiSight assessment study Spain (MASS)
-
Francisco Luis Prieto-Garrido [1] ; Jose Luis Hernández Verdejo [1] ; César Villa-Collar [2] ; Alicia Ruiz-Pomeda [3]
-
[1] Universidad Complutense de Madrid
Universidad Complutense de Madrid
Madrid, España
-
[2] Universidad Europea de Madrid
Universidad Europea de Madrid
Madrid, España
-
[3] Hospital de Móstoles
Hospital de Móstoles
Móstoles, España
-
- Localización: Journal of Optometry: peer-reviewed Journal of the Spanish General Council of Optometry, ISSN-e 1888-4296, Vol. 15, Nº. 1, 2022, págs. 78-87
- Idioma: inglés
- Enlaces
-
Resumen
Purpose To investigate which baseline factors are predictive for success in controlling myopia progression in a group of children wearing MiSight Contact Lens (CLs).
Methods Myopic patients (n=41) fitted with MiSight CLs and followed up two years were included in this study. Bivariate analysis, a logistic regression analysis (LG) and a decision tree (DT) approach were used to screen for the factors influencing the success of the treatment. To assess the response, axial length (AL) changes were considered as main variable. Patients were classified based on a specific range of change of axial length at the end of each year of treatment as “responders” (R) (AL change <0.11mm/per year) and “non-responders” (NR) (AL change ≥0.11mm/per year).
Results Of a total of forty-one Caucasian patients treated with MiSight CLs, 21 and 16 were considered responders in the first and the second year of follow-up, respectively. LG analysis showed that the only factor associated with smaller axial length growth was more time spent outdoors (p=0.0079) in the first year of treatment. The decision tree analysis showed that in the responding group spending more than 3 and 4h outdoors per week was associated with the best response in the first year and in the second year of treatment respectively.
Conclusions The LR and the DT approach of this pilot study identifies time spent outdoors as a main factor in controlling axial eye growth in children treated with MiSight CLs.
